Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Brexit freight plans needed urgently, says drug, medical suppliers

      Brexit freight plans needed urgently, says drug, medical suppliers

      Medical Dialogues Bureau21 Sept 2019 9:00 AM IST
      U.S: Some larger pharmaceutical companies have opted to make their own plans to replenish supplies of critical medicines in the event of a “no-deal”...
      No cancer causing impurities found in BP drug Valsartan during initial approval process, says DCGI

      No cancer causing impurities found in BP drug Valsartan during initial approval process, says DCGI

      Medical Dialogues Bureau20 Sept 2019 4:02 PM IST
      V G Somani said, according to the information he had the impurities were not found during the initial approval process of the product (Valsartan)....
      Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

      Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

      Medical Dialogues Bureau20 Sept 2019 2:33 PM IST
      The Hyderabad Pharma City project has received an overwhelming response from the industry stakeholders, Telangana Minister for IT and Industries KT...
      Merck Ebola Vaccine V920 up for USFDA review

      Merck Ebola Vaccine V920 up for USFDA review

      Medical Dialogues Bureau20 Sept 2019 9:30 AM IST
      New Delhi: Merck, known as MSD outside the United States and Canada, recently announced that the U.S. Food and Drug Administration (FDA) has accepted...
      GSK fights bid to strike new Zofran preemption evidence

      GSK fights bid to strike new Zofran preemption evidence

      Medical Dialogues Bureau20 Sept 2019 9:00 AM IST
      U.S. District Judge F. Dennis Saylor during a hearing in Boston asked why some of GSK's witnesses should be allowed to put forward new opinions to...
      Lupin gets USFDA warning letter for Mandideep Unit-1 facility

      Lupin gets USFDA warning letter for Mandideep Unit-1 facility

      Medical Dialogues Bureau19 Sept 2019 1:07 PM IST
      Commenting on the same, Lupin said, "The Company does not believe that the warning letter will have an impact on the disruption of supplies or the...
      Twin Approvals: Abbott bags CE Mark for its Mechanical Heart Valve and Occluder devices

      Twin Approvals: Abbott bags CE Mark for its Mechanical Heart Valve and Occluder devices

      Medical Dialogues Bureau19 Sept 2019 12:17 PM IST
      ABBOTT PARK -- Abbott today announced approvals in Europe for two of its life-saving pediatric devices. The Masters HP™ 15mm rotatable mechanical...
      Mylan launches generic version of Faslodex Injection to treat breast cancer

      Mylan launches generic version of Faslodex Injection to treat breast cancer

      Medical Dialogues Bureau19 Sept 2019 9:35 AM IST
      New Delhi: Mylan N.V. recently announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic...
      Roche wins USFDA breakthrough status for Gayzva for lupus nephritis

      Roche wins USFDA breakthrough status for Gayzva for lupus nephritis

      Medical Dialogues Bureau18 Sept 2019 9:45 AM IST
      Roche Gazyva is an engineered monoclonal antibody designed to attach to CD20, a protein found only on certain types of B-cells. It is thought to work...
      Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics

      Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics

      Medical Dialogues Bureau18 Sept 2019 9:30 AM IST
      This new, non-exclusive collaboration reflects both Medtronic plc and Novo Nordisk commitment to make diabetes management easier by integrating key...
      Sanskritech unveils self-monitoring health diagnostic system Swayam AHM in India

      Sanskritech unveils self-monitoring health diagnostic system Swayam AHM in India

      Medical Dialogues Bureau18 Sept 2019 9:29 AM IST
      Swayam is a futuristic diagnostic system as it is a one-of-its-kind machine that is portable, sophisticated and is integrated with clinical-grade...
      After Michigan, NY state bans flavoured e-cigarettes over vaping concerns

      After Michigan, NY state bans flavoured e-cigarettes over vaping concerns

      Medical Dialogues Bureau18 Sept 2019 9:15 AM IST
      The ban comes into force with immediate effect. Michigan became the first state to declare a ban earlier this month, but that law has yet to be...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok